Mangoceuticals, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Mangoceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $272.00K, a 36.86% decline year-over-year.
- Mangoceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $1.32M.
- Mangoceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $430.79K, a 10.95% increase year-over-year.
- Mangoceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $655.00K, a 263.89% increase year-over-year.
- Mangoceuticals, Inc. stock issued during period, value, new issues for fiscal 2025 was $4.63M, a 248.29% increase from fiscal 2024.
- Mangoceuticals, Inc. stock issued during period, value, new issues for fiscal 2024 was $1.33M, a 78.58% decline from fiscal 2023.
- Mangoceuticals, Inc. stock issued during period, value, new issues for fiscal 2023 was $6.20M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $272.00K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $4.63M 10-K · filed 2026-04-01 | |
| 2025-09-30 | $1.32M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $430.79K 10-Q/A · filed 2025-11-14 | |
| 2025-03-31 | $655.00K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $1.33M 10-K · filed 2026-04-01 | |
| 2024-06-30 | $388.27K 10-Q/A · filed 2025-11-14 | |
| 2024-03-31 | $180.00K 10-Q/A · filed 2025-11-14 | |
| 2023-12-31 | $6.20M 10-K · filed 2025-03-20 | |
| 2023-06-30 | $1.02M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $5.00M 10-Q · filed 2024-11-14 | |
| 2022-09-30 | $1.50M 10-Q · filed 2023-10-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |